Searched for
VACCINE PIVOT
To win the deep-tech race, India needs ‘General Innovation Rules’India is launching ambitious science initiatives. However, current financial rules designed for conventional procurement hinder R&D. A new ...- Rare earth, gas supply, aircraft parts: What’s inside the new IIP calculus as India revises base yearIndia is updating its Index of Industrial Production. The new series will use 2022-23 as the base year, replacing the old 2011-12 base. Thi...
- 90.6% hospital births, 96% plus vaccinations: NFHS-6 reflects India's "accelerated progress" in family health parametersIndia's National Family Health Survey-6 shows significant improvements in maternal and child health. Vaccinations and antenatal care have i...
- "India has scientific capability to emerge as global leader in health technologies": NITI Aayog's Gobardhan DasIndia's largest biomedical event, 'Medical Innovations Patent Mitra: Innovators-to-Industry Connect', successfully took place in New Delhi....
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- Quote of the Day by Melinda French Gates: 'It's the mark of a backward society when...'—Top quotes by the co-founder of the Gates Foundation who's consistently listed among Forbes' 100 most powerful womenQuote of the Day: Melinda French Gates states that societies move backward when men make decisions for women. Her words champion equality a...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Today in US history on April 12: From the outbreak of civil war to civil rights, public health breakthroughs, and the dawn of the space shuttle eraApril 12th holds significant weight in American history. It witnessed the start of the Civil War at Fort Sumter in 1861. President Franklin...
- Bharat Biotech, Biofabri in tech transfer deal for TB vaccineMTBVAC, the TB vaccine, has undergone Phase I and II clinical trials in India. The vaccine has demonstrated safety and immunogenicity. Base...
- Sharad Pawar advocates Bharat Ratna for SII founder Cyrus PoonawallaNCP chief Sharad Pawar has proposed Cyrus Poonawalla, the founder of the Serum Institute of India (SII), for the prestigious Bharat Ratna a...
- Study links AstraZeneca's Covid vaccine to higher risk of very rare clotSeveral countries have already altered their advice after previous research indicated that, in rare number of cases, thrombosis with thromb...
- India, US to facilitate joint research, information sharing to address global health challengesThe two countries have reaffirmed their commitment to facilitate joint research and information sharing to address barriers to pandemic-rel...
- Production of another COVID-19 vaccine to begin in weeksIf the trial is successful, regulators could approve the vaccine for use in the last three months of the year, the drugmakers said in a sta...
- Strategic PlanningWhat are the key challenges that will drive the longer-term change agenda? We would highlight three pivotal themes that will drive many oth...
- United Nations backed coronavirus vaccine delivery program, Gavi, warns of supply delaysThe move will affect up to 40 million doses of the Oxford University-AstraZeneca vaccines being manufactured by the Serum Institute that we...
- Risk of a second wave of Covid-19 in India has risen materially: NomuraThe increased caseload could lead to near-term growth concerns and delay market expectations on the timing of policy normalisation, global ...
- Business activity almost back to normal in India: NomuraThe Nomura India Business Resumption Index (NIBRI) sharply picked up to 96.5 for the week ending February 7, from 94.4 in the previous week...
- Post jabs, India may get back on its feet in 2nd half of 2021The country’s Covid-19 vaccination drive, which begins Saturday, is likely to cost 0.2-0.5% of gross domestic product (GDP), according to e...
- Nomura projects India to be the fastest growing Asian economy in 2021The Japanese brokerage turned positive on India’s cyclical outlook, with near term risks of a resurgent pandemic unlikely to derail growth,...
- Moderna says discussing supply deals with countries for COVID-19 vaccineLast week, Moderna announced the start of a late-stage trial on 30,000 people to demonstrate that its vaccine was safe and effective, the f...
Load More
